Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
GWRS
Deeply overvalued
Global Water Resources, Inc.
Price$8.71
Model IV$5.65
P/IV1.29
Premium +54%
Return to IV: -35.1%
GWW
Deeply overvalued
W.W. GRAINGER, INC.
Price$1,266.61
Model IV$587.90
P/IV2.10
Premium +115%
Return to IV: -53.6%
Owner yield 2.5%
10-yr IRR 1.8% · moderate
Market implies +18.0%/yr
vs model +9.7% · above model
GXAI
Undervalued
GAXOS.AI INC.
Price$0.65
Model IV$0.77
P/IV1.54
Discount 15%
Return to IV: +17.9%
Market implies -11.3%/yr
vs model +15.0% · below model
GXO
Deeply undervalued
GXO Logistics, Inc.
Price$45.84
Model IV$137.60
P/IV0.36
Discount 67%
Return to IV: +200.2%
Market implies -17.1%/yr
vs model +13.5% · below model
GXRP
Valuation N/A
Grayscale XRP Trust ETF
Price$26.37
Model IV—
P/IV—
GYRE
Undervalued
GYRE THERAPEUTICS, INC.
Price$6.73
Model IV$9.54
P/IV0.62
Discount 29%
Return to IV: +41.8%
Market implies -6.5%/yr
vs model +49.9% · below model
GYRO
Deeply overvalued
Gyrodyne, LLC
Price$5.05
Model IV$3.26
P/IV2.17
Premium +55%
Return to IV: -35.5%
H
Valuation N/A
Hyatt Hotels Corp
Price$163.07
Model IV—
P/IV—
Owner yield 2.6%
10-yr IRR 6.2% · grower
Market implies +42.1%/yr
vs model +21.1% · above model
HACQ
Valuation N/A
HCM IV Acquisition Corp.
Price$10.08
Model IV—
P/IV—
HACQU
Valuation N/A
HCM IV Acquisition Corp.
Price$10.15
Model IV—
P/IV—
HACQW
Valuation N/A
HCM IV Acquisition Corp.
Price$0.43
Model IV—
P/IV—
HAE
Deeply undervalued
HAEMONETICS CORP
Price$102.69
Model IV$171.50
P/IV0.40
Discount 40%
Return to IV: +67.0%
Owner yield 3.8%
10-yr IRR 7.5% · moderate
Market implies +1.8%/yr
vs model +10.4% · below model
HAFC
Fairly valued
HANMI FINANCIAL CORP
Price$31.80
Model IV$30.32
P/IV0.99
Premium +5%
Return to IV: -4.7%
HAFN
Valuation N/A
Hafnia Ltd
Price$9.38
Model IV—
P/IV—
HAIN
Valuation N/A
HAIN CELESTIAL GROUP INC
Price$0.62
Model IV—
P/IV—
Market implies -12.5%/yr
vs model +4.9% · below model
HAL
Deeply undervalued
HALLIBURTON CO
Price$33.64
Model IV$52.95
P/IV0.73
Discount 36%
Return to IV: +57.4%
Owner yield 7.2%
10-yr IRR 14.9% · moderate
Market implies +0.6%/yr
vs model +8.0% · below model
HALO
Deeply undervalued
HALOZYME THERAPEUTICS, INC.
Price$107.94
Model IV$316.93
P/IV0.21
Discount 66%
Return to IV: +193.6%
Owner yield 3.7%
10-yr IRR 10.7% · grower
Market implies +4.8%/yr
vs model +25.0% · below model
HAO
Valuation N/A
Haoxi Health Technology Ltd
Price$2.86
Model IV—
P/IV—
Market implies +26.8%/yr
vs model +2.0% · above model
HAS
Deeply overvalued
HASBRO, INC.
Price$87.57
Model IV$44.55
P/IV1.93
Premium +97%
Return to IV: -49.1%
Owner yield 5.9%
10-yr IRR 3.4% · steady
Market implies +5.3%/yr
vs model -2.9% · above model
HASI
Deeply overvalued
HA Sustainable Infrastructure Capital, Inc.
Price$36.43
Model IV$24.02
P/IV1.71
Premium +52%
Return to IV: -34.1%
HAVA
Valuation N/A
Harvard Ave Acquisition Corp
Price$10.21
Model IV—
P/IV—
HAVAR
Valuation N/A
Harvard Ave Acquisition Corp
Price$0.15
Model IV—
P/IV—
HAVAU
Valuation N/A
Harvard Ave Acquisition Corp
Price$10.23
Model IV—
P/IV—
HAWK
Valuation N/A
HawkEye 360, Inc.
Price$16.30
Model IV—
P/IV—
HAYW
Deeply overvalued
Hayward Holdings, Inc.
Price$13.11
Model IV$7.93
P/IV1.78
Premium +65%
Return to IV: -39.5%
Owner yield 6.6%
10-yr IRR 5.5% · steady
Market implies +3.7%/yr
vs model -2.0% · above model
HBAN
Fairly valued
HUNTINGTON BANCSHARES INC /MD/
Price$15.88
Model IV$16.52
P/IV0.99
Discount 4%
Return to IV: +4.0%
HBANL
Deeply overvalued
HUNTINGTON BANCSHARES INC /MD/
Price$25.01
Model IV$18.34
P/IV1.37
Premium +36%
Return to IV: -26.7%
HBANM
Fairly valued
HUNTINGTON BANCSHARES INC /MD/
Price$19.88
Model IV$18.34
P/IV1.17
Premium +8%
Return to IV: -7.7%
HBANP
Fairly valued
HUNTINGTON BANCSHARES INC /MD/
Price$16.25
Model IV$18.34
P/IV0.91
Discount 11%
Return to IV: +12.9%
HBANZ
Fairly valued
HUNTINGTON BANCSHARES INC /MD/
Price$19.09
Model IV$18.34
P/IV1.11
Premium +4%
Return to IV: -3.9%
HBB
Fairly valued
Hamilton Beach Brands Holding Co
Price$30.00
Model IV$32.05
P/IV0.63
Discount 6%
Return to IV: +6.8%
Owner yield 13.0%
10-yr IRR 21.2% · steady
Market implies -0.2%/yr
vs model +3.7% · below model
HBCP
Fairly valued
HOME BANCORP, INC.
Price$69.22
Model IV$61.01
P/IV1.06
Premium +13%
Return to IV: -11.9%
HBIO
Valuation N/A
HARVARD BIOSCIENCE INC
Price$8.03
Model IV—
P/IV—
Market implies +37.0%/yr
vs model +2.0% · above model
HBM
Valuation N/A
Hudbay Minerals Inc.
Price$26.52
Model IV—
P/IV—
HBNB
Valuation N/A
Hotel101 Global Holdings Corp.
Price$4.99
Model IV—
P/IV—
HBNC
Deeply overvalued
HORIZON BANCORP INC /IN/
Price$19.78
Model IV$9.90
P/IV1.87
Premium +100%
Return to IV: -49.9%
HBT
Overvalued
HBT Financial, Inc.
Price$36.68
Model IV$28.38
P/IV1.01
Premium +29%
Return to IV: -22.6%
HCA
Deeply undervalued
HCA Healthcare, Inc.
Price$427.71
Model IV$1,284.29
P/IV0.29
Discount 67%
Return to IV: +200.3%
Owner yield 5.9%
10-yr IRR 14.7% · moderate
Market implies -4.4%/yr
vs model +11.6% · below model
HCAC
Valuation N/A
Hall Chadwick Acquisition Corp
Price$10.10
Model IV—
P/IV—
HCACR
Valuation N/A
Hall Chadwick Acquisition Corp
Price$0.25
Model IV—
P/IV—
HCACU
Valuation N/A
Hall Chadwick Acquisition Corp
Price$10.38
Model IV—
P/IV—
HCAI
Deeply undervalued
Huachen AI Parking Management Technology Holding Co., Ltd
Price$0.61
Model IV$2.39
P/IV3.39
Discount 75%
Return to IV: +292.3%
Market implies -28.1%/yr
vs model +2.0% · below model
HCAT
Deeply undervalued
Health Catalyst, Inc.
Price$1.70
Model IV$4.85
P/IV0.28
Discount 65%
Return to IV: +185.5%
Market implies -18.4%/yr
vs model +6.5% · below model
HCC
Fairly valued
WARRIOR MET COAL, INC.
Price$95.46
Model IV$90.09
P/IV1.05
Premium +6%
Return to IV: -5.6%
Market implies +4.9%/yr
vs model +5.0% · in line
HCHL
Valuation N/A
Happy City Holdings Ltd
Price$3.96
Model IV—
P/IV—
HCI
Fairly valued
HCI Group, Inc.
Price$185.73
Model IV$180.76
P/IV0.85
Premium +3%
Return to IV: -2.7%
HCIC
Valuation N/A
Hennessy Capital Investment Corp. VIII
Price$9.99
Model IV—
P/IV—
HCICR
Valuation N/A
Hennessy Capital Investment Corp. VIII
Price$0.14
Model IV—
P/IV—
HCICU
Valuation N/A
Hennessy Capital Investment Corp. VIII
Price$10.12
Model IV—
P/IV—
HCKT
Undervalued
HACKETT GROUP, INC.
Price$10.98
Model IV$13.69
P/IV0.84
Discount 20%
Return to IV: +24.7%
Owner yield 11.9%
10-yr IRR 23.0% · moderate
Market implies +1.0%/yr
vs model +7.4% · below model
HCM
Valuation N/A
HUTCHMED (China) Ltd
Price$12.82
Model IV—
P/IV—
Market implies +23.2%/yr
vs model +11.4% · above model
HCMA
Valuation N/A
HCM III ACQUISITION CORP.
Price$10.32
Model IV—
P/IV—
HCMAU
Valuation N/A
HCM III ACQUISITION CORP.
Price$10.47
Model IV—
P/IV—
HCMAW
Valuation N/A
HCM III ACQUISITION CORP.
Price$0.63
Model IV—
P/IV—
HCSG
Undervalued
HEALTHCARE SERVICES GROUP INC
Price$21.91
Model IV$26.29
P/IV0.78
Discount 17%
Return to IV: +20.0%
Owner yield 4.2%
10-yr IRR 5.5% · steady
Market implies +1.3%/yr
vs model +5.6% · below model
HCTI
Valuation N/A
Healthcare Triangle, Inc.
Price$0.75
Model IV—
P/IV—
HCWB
Valuation N/A
HCW Biologics Inc.
Price$2.24
Model IV—
P/IV—
Market implies +29.2%/yr
vs model +15.0% · above model
HCWC
Valuation N/A
HEALTHY CHOICE WELLNESS CORP.
Price$9.88
Model IV—
P/IV—
Market implies +46.5%/yr
vs model +14.5% · above model
HCXY
Valuation N/A
Hercules Capital, Inc.
Price$25.04
Model IV—
P/IV—
HD
Deeply overvalued
HOME DEPOT, INC.
Price$299.98
Model IV$206.27
P/IV1.45
Premium +45%
Return to IV: -31.2%
Owner yield 5.1%
10-yr IRR 6.7% · steady
Market implies +8.4%/yr
vs model +3.9% · above model